Pharmacy Groups Applaud Senate Finance Committee’s Bipartisan Effort to Relieve DIR Fees

National pharmacy organizations once again applaud the Senate Finance Committee’s bipartisan effort to relieve DIR fees.  Senate Finance Committee Chair Chuck Grassley, Ranking Member Ron Wyden, and 23 members of the committee (over 80% of the committee) signed a letter send to HHS Secretary Alex Azar and CMS Administrator Seema Verma urging them to to “revive the pharmacy DIR reforms included in [CMS’] November 30, 2018 proposed rule, ‘Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses,’ (CMS-4180-P), and finalize them for plan year 2021.”

Eight pharmacy organizations applauded this effort including NASPA, National Community Pharmacists Association; National Association of Chain Drug Stores; National Association of Specialty Pharmacy; American Pharmacists Association; Food Marketing Institute; National Grocers Association; and American Society of Consultant Pharmacists.  They stated: “This letter reflects the strong bipartisan recognition that pharmacy DIR fees must be stopped to prevent harm to patients and to the pharmacies that serve them – harm that is egregious and escalating. The Senate Finance Committee members stated clearly the importance of this issue to patients and to pharmacies; the concerns regarding Medicare Part D plan and pharmacy benefit manager (PBM) practices; the economic factors that are necessary to consider when accurately evaluating the importance of DIR fee relief; and the policies that are necessary to deliver true reform.”

Read More

Leave a Reply